文献速递腹部技术与安全MR

Fontan相关肝病中HCC与FNH的Gd-EOB-DTPA动态增强MRI特征

Hepatocellular carcinoma and focal nodular hyperplasia in patients with Fontan-associated liver disease: characterisation using dynamic gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MRI.
PubMed 文献 · Clin Radiol · 2022-12-05

FALD-HCC表现为弱早期强化和轻度延迟期廓清,FALD-FNH表现为明显早期强化并持续至延迟期;各期信号强度比值FALD-HCC均显著低于FALD-FNH,提示该时间信号曲线有助于鉴别两者。

要点

  • FALD-HCC呈弱早期强化、轻度延迟期廓清,FALD-FNH呈明显持续强化。
  • 各期肿瘤/肝信号强度比值FALD-HCC均显著低于FALD-FNH(15分钟p<0.001)。
  • FALD-HCC与HCV-HCC仅在30秒时信号比值有显著差异(p<0.05)。

关键影像表现/征象

  • FALD-HCC表现为弱早期强化伴延迟期轻度廓清。
  • FALD-FNH表现为明显早期强化并持续至延迟期。
  • FALD-HCC各期肿瘤/肝信号强度比值均显著低于FALD-FNH。
  • FALD-HCC与HCV-HCC仅在30秒时信号比值显著更低(p<0.05),其他期廓清更差。
  • 15分钟时FALD-HCC信号比值显著低于FALD-FNH(p<0.001)。

诊断标准与关键数值

  • 肿瘤/肝信号强度比值于30、60、100、180秒及15分钟测量,用于比较FALD-HCC、FALD-FNH与HCV-HCC。
  • FALD-HCC与FALD-FNH各期信号比值差异显著;FALD-HCC与HCV-HCC仅30秒差异显著(p<0.05);15分钟FALD-HCC vs FALD-FNH p<0.001。

临床应用与阅片要点

  • 对FALD患者肝结节行动态Gd-EOB-DTPA增强MRI时,应关注早期强化程度及延迟期廓清模式。
  • 弱早期强化伴轻度廓清提示FALD-HCC可能,明显持续强化提示FALD-FNH可能。
  • FALD-HCC廓清程度较HCV-HCC更轻,判读时不应套用普通HCC典型廓清标准。

局限性

  • 对照组为HCV相关HCC,年龄与FALD组差异较大。
  • 单中心前瞻性设计,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To identify the characteristic diagnostic features of hepatocellular carcinoma (HCC) and focal nodular hyperplasia (FNH) in Fontan-associated liver disease (FALD) patients using dynamic gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).

MATERIALS AND METHODS: Thirty-one FALD patients (mean age, 28.3 ± 7.2 years) with liver nodules who underwent dynamic Gd-EOB-DTPA-enhanced MRI were enrolled prospectively. Twenty-five patients (mean age, 72.8 ± 11.4 years) with hepatitis C virus (HCV)-related HCC constituted the control group. The tumour-to-liver signal intensity (SI) ratio was measured at 30, 60, 100, 180 seconds and 15 minutes, and the SI ratio was compared among FALD-HCC, FALD-FNH, and HCV-HCC.

RESULTS: FALD-HCC exhibited weak early enhancement with mild washout in late phases. FALD-FNH exhibited marked early enhancement that continued until the late phases. The SI ratio was significantly lower for FALD-HCC than for FALD-FNH in all phases. The SI ratio was significantly lower for FALD-HCC than for HCV-HCC only at 30 seconds (p<0.05), whereas poorer washout was seen in FALD-HCC than HCV-HCC in other phases. In 15 minutes, FALD-HCC had a significantly lower SI ratio compared to FALD-FNH (p<0.001).

CONCLUSIONS: The time course of Gd-EOB-DTPA-enhanced MRI signal intensity in FALD-HCC was different from that in FALD-FNH or HCV-HCC. This imaging finding may be useful adjunctive information to distinguish FALD-HCC from FALD-FNH.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Shiina, Inai, Sakai, et al. Hepatocellular carcinoma and focal nodular hyperplasia in patients with Fontan-associated liver disease: characterisation using dynamic gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MRI. Clin Radiol. 2022. PMID: 36481111. doi:10.1016/j.crad.2022.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。